Navigation Links
Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
Date:1/17/2013

cal specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com  or follow @ExpressScripts on Twitter.

Contact Information:
Jeff Hall , Chief Financial Officer
David Myers , Vice President Investor Relations
(314) 810-3115
Investor.relations@express-scripts.com


'/>"/>
SOURCE Express Scripts Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Express Scripts to Present at Bank of America Merrill Lynch Conference
2. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
3. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
4. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5. Generex Augments Antigen Express Scientific Advisory Board
6. Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
7. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
8. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
9. Express Scripts Holding Company Announces Second Quarter 2012 Earnings Conference Call
10. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
11. Express Scripts Reports Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 2015 Research and Markets ... of the "Lab Accessories Market by ... Station) & End User (OEM/Biotechnology & Pharmaceutical ... 2020" report to their offering. ... expected to reach $504.7 million by 2020 ...
(Date:4/24/2015)... Company, Inc. (NYSE: LCI ) today announced that ... facility to $120 million from $50 million.  The amended ... company to increase borrowings by a total of up ... commitments from existing lenders or new lending institutions.  The ... 2018.   "The amended credit facility, together ...
(Date:4/23/2015)... CHICAGO, Ill. , April 24, 2015  AbbVie ... Food and Drug Administration (FDA) has accepted its New ... company,s, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, ... for the treatment of adults with chronic genotype 4 ... regimen is the first all-oral, interferon-free therapy being evaluated ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Lannett Expands Revolving Credit Facility To $120 Million 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
(Date:4/24/2015)... The first step to transforming one’s ... For meditation and yoga teacher Stine Koppernæs, meditation and ... tools that allow her to experience more peace and ... a teacher since 2006, and through the years she ... being. , “I love sharing this way of finding ...
(Date:4/24/2015)... Carinsurancequotesinfo.com has released a new blog ... to qualify for auto insurance as a ... auto insurance online, without having to follow a special ... parents can reduce their auto insurance expenses. The tips ... explained. , Clients can now visit an insurance ...
(Date:4/24/2015)... Integrative Therapeutics has introduced two new supplements ... , A unique combination of herbs and nutrients, ... Complex apart from other antioxidant supplements. This formula ... antioxidation versus the use of single or sequential ... Resveratrol, Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 with Setria® ...
(Date:4/24/2015)... Orlando, Fla. (PRWEB) April 24, 2015 ... extraordinary healer” were among the ways Denise Weiner described ... Angeles, who cared for her daughter, Alexa, during her ... radiation, brain resections, a bone marrow transplant and numerous ... the house to visit Alexa when she was not ...
(Date:4/24/2015)... 2015 Insuranceautoquote.info has released a new ... premiums . , Lowering auto insurance prices is ... simply find better offers for their financial budget. Comparing ... does not require any registration. , Comparing quotes ... are multiple agencies that sell coverage and this means ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2
... June 23, 2009 With millions of people in the ... and our Canadian neighbors doing likewise for their July 1 ... shows of the future likely to ignite a smile on ... is quietly making its way toward the sky. ...
... HIV/AIDS Atlas , , WASHINGTON, June 22 ... HIV/AIDS Atlas ( http://www.MapHIV.org ) that highlights the impact ... States. The Atlas makes information on HIV/AIDS prevalence ... time, painting a comprehensive picture of the varying intensity ...
... Quality Forum Launches First U.S. HIV/AIDS Atlas , , ... launched a groundbreaking HIV/AIDS Atlas ( http://www.MapHIV.org ... in communities across the United States. The Atlas makes ... for the first time, painting a comprehensive picture of the ...
... Economy! It,s the Perfect Time for Fitness! , , LOS ... or stair climber in the park or along the beach. Now ... putting the traditional fitness equipment on wheels, but with a unique ... Pumgo Fitness Scooter, a new concept of fitness, will be introduced ...
... Biomodels CRO expertise in $1 billion market for cancer ... , , WATERTOWN, Mass., June 22 Biomodels ... care, today announced that its customized research program allowed ... attain Food and Drug Administration (FDA) approval for Phase ...
... in the Bone Graft Market , , MOUNTAIN VIEW, ... bone graft market, Frost & Sullivan recognizes Bone Solutions, Inc. ... Technology Leadership of the Year for its development of OsteoCrete(TM). ... and tendons to bone and bone-to-bone. On May 21, ...
Cached Medicine News:Health News:'Green' fireworks may brighten eco-friendly 4th of July displays in future 2Health News:MapHIV.org Shows Six Counties in Louisiana Seriously Impacted by AIDS 2Health News:MapHIV.org Shows Six Counties in Louisiana Seriously Impacted by AIDS 3Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 2Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 3Health News:Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 2Health News:Biomodels' Oral Mucositis Expertise Speeds FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients 2Health News:Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award 2Health News:Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award 3Health News:Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award 4
... have proven that the management of diabetes in ... levels is the most effective way to reduce ... aimed at maintaining or improving a diabetes patients ... costly. , ,These have been the guiding ...
... about insulin dosages and other medication, about ... by data from blood glucose tests and ... that can be seen by you and ... is presented in organized and graphical formats. ...
... Green Photocoagulator - Portable and rugged solid-state ... clinic, and operating room. Built to high-duty ... the most demanding environments, the Novus Verdi ... A full line of accessories for private ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: